Journal
LIFE-BASEL
Volume 12, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/life12081203
Keywords
heart failure; myocardial iron metabolism; oxidative stress; myocardial gathering proteins expression; human model
Categories
Funding
- Cardinal Stefan Wyszynski National Institute of Cardiology [3.15/VII/18]
Ask authors/readers for more resources
Heart failure (HF) is a common disease and iron deficiency (ID) plays a significant role in worsening the condition of HF patients. Iron supplementation is recommended but may have adverse effects. There are still many knowledge gaps regarding the interaction between iron deficiency and HF. Summarizing the latest translational and clinical research on iron deficiency in HF is important for raising awareness among clinicians.
Heart failure (HF) is a common disease that causes significant limitations on the organism's capacity and, in extreme cases, leads to death. Clinically, iron deficiency (ID) plays an essential role in heart failure by deteriorating the patient's condition and is a prognostic marker indicating poor clinical outcomes. Therefore, in HF patients, supplementation of iron is recommended. However, iron treatment may cause adverse effects by increasing iron-related apoptosis and the production of oxygen radicals, which may cause additional heart damage. Furthermore, many knowledge gaps exist regarding the complex interplay between iron deficiency and heart failure. Here, we describe the current, comprehensive knowledge about the role of the proteins involved in iron metabolism. We will focus on the molecular and clinical aspects of iron deficiency in HF. We believe that summarizing the new advances in the translational and clinical research regarding iron deficiency in heart failure should broaden clinicians' awareness of this comorbidity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available